<DOC>
	<DOCNO>NCT01800305</DOCNO>
	<brief_summary>The object randomize , parallel , positive control study explore pharmacokinetics pharmacodynamics profile test drug single-dose subcutaneous administration , compare comparator drug ( EPIAO® ) multiple-dose subcutaneous administration , assess plasma concentration drug reticulocyte count , hemoglobin concentration hematocrit follow subcutaneous administration , evaluate security tolerability test drug healthy subject , provide sufficient information dose selection future phase II III study .</brief_summary>
	<brief_title>PK &amp; PD Study Pegylated rhEPO , Evaluated Its Safety Tolerability Male Healthy Individual</brief_title>
	<detailed_description />
	<criteria>Agree purpose study sign date informed consent . Male , age 18 40 year , age disparity group le 10 year . Body weight ≥ 50kg , body mass index ( BMI ) 18 kg/m2 26kg/m2 screening . Hemoglobin 131g/L 162g/L , hematocrit 41 % 49 % , reticulocyte 0.5 % 2 % . Transferrin saturation serum ferritin normal range . Physical condition : vital sign , physical examination laboratory test ( include routine blood , biochemical test , coagulation indicator , serum folic acid , vitamin B12 , urine test , HBsAg , antiHCV , antiHIV , Immunoglobulin ( IgA , IgM , IgG ) , thyroid function ( T3 , T4 , TSH ) , autoantibody ) , chestXray , 12lead ECG normal range , without significant clinically abnormal . Presence organic disease heart , liver , kidney , brain ; presence cardiovascular , pulmonary , gastrointestinal , urinary , neurological , endocrine , immunity , genitourinary system disease . Subjects familial genetic disease , mental illness , physical disability . History drug allergy . Orthostatic hypotension , systolic blood pressure &lt; 90mmHg . Habitual medication , include Chinese herbal medicine . Poor inclusion condition ( e.g . infirm ) . Smoker ( smoke everyday 7 cigarette per week ) ，alcoholics ( 40g/day , equivalent 100ml/day 50 degree white spirit ) . Participate drug trial subject within previous 3 month . As blood donate within previous 3 month , experience massive blood loss due trauma surgery . Other condition opinion investigator preclude enrollment study ( e.g . poor compliance ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>PK &amp; PD study</keyword>
	<keyword>rhEPO</keyword>
	<keyword>Pegylated rhEPO</keyword>
	<keyword>male healthy subject</keyword>
</DOC>